Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01787682 · ClinicalTrials.gov registry record · NA

Nutritional and Functional Changes in Heart Failure and COPD

A NA study, sponsored by Texas A&M University.

Completed
Registry status
NA
Development phase
99
Enrollment target

NCT01787682 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 99 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01787682, a NA study, has completed, sponsored by Texas A&M University.

COMPLETED
Registry status
NA
Development phase
99 participants
Enrollment target

Study Summary

Weight loss commonly occurs in patients with chronic heart failure (CHF) and chronic obstructive pulmonary disorder (COPD), negatively influencing their quality of life, treatment response and survival. Loss of muscle protein is generally a central component of weight loss in CHF and COPD patients but patients also have reductions in fat mass and bone density, independent of the severity of the disease state. The purpose of this cross-sectional study is to provide detailed insight in disease related gut function by obtaining information on gut permeability, digestion and absorption of glucose, fat and protein in CHF and COPD patients compared to matched healthy controls. This will provide required information that is necessary to implement new strategies to develop optimal nutritional regimen in CHF and COPD. The hypothesis is that CHF and COPD are related to decreased gut function and absorption, leading to decreased anabolic response. Second, this decreased nutritional status is linked to reduced muscle functioning and possibly decreased cognition. In addition, we will examine the effect of aging on by comparing gut function digestion and absorption of the CHF and COPD aged matched healthy controls to a group of young healthy subjects.

Interventions

  • DIETARY_SUPPLEMENT BOOST High Protein

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2012-12
Est. Completion 2017-09-17
Phase NA

Sponsor

Texas A&M University

95 total trials

What the Registry Record Tells You About NCT01787682

The ClinicalTrials.gov registry entry for NCT01787682 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which BOOST High Protein is the first listed.

NCT01787682 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01787682 about?

NCT01787682 is a clinical study titled "Nutritional and Functional Changes in Heart Failure and COPD". Weight loss commonly occurs in patients with chronic heart failure (CHF) and chronic obstructive pulmonary disorder (COPD), negatively influencing their quality of life, treatment response and survival. Loss of muscle protein is generally a central component of weight loss in CHF and COPD patients b...

What is the current status of trial NCT01787682?

This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2012-12. Estimated completion is 2017-09-17.

What interventions are being tested in trial NCT01787682?

The interventions under investigation include: BOOST High Protein (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01787682?

This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.